Cargando…
Drug induced oral erythema multiforme: Case report
INTRODUCTION: Drug induced oral erythema multiforme a rare clinical entity which involves only the lips and oral mucosa without skin involvement. These lesions are difficult in diagnosing with other oral ulcerative lesions with similar clinical manifestations. PATIENT CONCERNS: This article presents...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084015/ https://www.ncbi.nlm.nih.gov/pubmed/33907086 http://dx.doi.org/10.1097/MD.0000000000022387 |
_version_ | 1783686065171726336 |
---|---|
author | Asif, Shaik Mohamed Shamsudeen, Shaik Mohamed Assiri, Khalil Ibrahim Muburak, Hussain Mohammed Al Kaleem, Sultan Mohammed Khan, Abdul Ahad Shariff, Mansoor |
author_facet | Asif, Shaik Mohamed Shamsudeen, Shaik Mohamed Assiri, Khalil Ibrahim Muburak, Hussain Mohammed Al Kaleem, Sultan Mohammed Khan, Abdul Ahad Shariff, Mansoor |
author_sort | Asif, Shaik Mohamed |
collection | PubMed |
description | INTRODUCTION: Drug induced oral erythema multiforme a rare clinical entity which involves only the lips and oral mucosa without skin involvement. These lesions are difficult in diagnosing with other oral ulcerative lesions with similar clinical manifestations. PATIENT CONCERNS: This article presents 2 case reports of Oral erythema multiforme in which drugs were the precipitating factor. Its etiopathogenesis, differential diagnosis and treatment modalities of the disease is discussed. DIAGNOSIS: Based on patient's complaints, drug history and clinical appearance, provisional diagnosis of drug induced erythema multiforme was considered. INTERVENTION: For case 1, patient was instructed to discontinue usage of drug and prescribed systemic steroid (Prednisolone 10 mg/d) for a week along with germicidal drugs to prevent secondary infection. Medication was tapered to 5 mg/d after first week. For case 2, patient was instructed to discontinue the drug and systemic steroid prednisolone 20 mg /d for 1 week with tapering dose of 10 mg/d for the second week was administered. OUTCOME: For case 1 and case 2 healing of the lesions were evident on third week of follow up. CONCLUSION: Medications should be taken under medical supervision. Over the counter drugs might lead to allergic reactions like drug induced oral erythema multiforme, which is a rare variant and needs to be differentiate from other oral ulcerative lesion for prompt management and follow-up. |
format | Online Article Text |
id | pubmed-8084015 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-80840152021-05-01 Drug induced oral erythema multiforme: Case report Asif, Shaik Mohamed Shamsudeen, Shaik Mohamed Assiri, Khalil Ibrahim Muburak, Hussain Mohammed Al Kaleem, Sultan Mohammed Khan, Abdul Ahad Shariff, Mansoor Medicine (Baltimore) 5900 INTRODUCTION: Drug induced oral erythema multiforme a rare clinical entity which involves only the lips and oral mucosa without skin involvement. These lesions are difficult in diagnosing with other oral ulcerative lesions with similar clinical manifestations. PATIENT CONCERNS: This article presents 2 case reports of Oral erythema multiforme in which drugs were the precipitating factor. Its etiopathogenesis, differential diagnosis and treatment modalities of the disease is discussed. DIAGNOSIS: Based on patient's complaints, drug history and clinical appearance, provisional diagnosis of drug induced erythema multiforme was considered. INTERVENTION: For case 1, patient was instructed to discontinue usage of drug and prescribed systemic steroid (Prednisolone 10 mg/d) for a week along with germicidal drugs to prevent secondary infection. Medication was tapered to 5 mg/d after first week. For case 2, patient was instructed to discontinue the drug and systemic steroid prednisolone 20 mg /d for 1 week with tapering dose of 10 mg/d for the second week was administered. OUTCOME: For case 1 and case 2 healing of the lesions were evident on third week of follow up. CONCLUSION: Medications should be taken under medical supervision. Over the counter drugs might lead to allergic reactions like drug induced oral erythema multiforme, which is a rare variant and needs to be differentiate from other oral ulcerative lesion for prompt management and follow-up. Lippincott Williams & Wilkins 2021-04-30 /pmc/articles/PMC8084015/ /pubmed/33907086 http://dx.doi.org/10.1097/MD.0000000000022387 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/) |
spellingShingle | 5900 Asif, Shaik Mohamed Shamsudeen, Shaik Mohamed Assiri, Khalil Ibrahim Muburak, Hussain Mohammed Al Kaleem, Sultan Mohammed Khan, Abdul Ahad Shariff, Mansoor Drug induced oral erythema multiforme: Case report |
title | Drug induced oral erythema multiforme: Case report |
title_full | Drug induced oral erythema multiforme: Case report |
title_fullStr | Drug induced oral erythema multiforme: Case report |
title_full_unstemmed | Drug induced oral erythema multiforme: Case report |
title_short | Drug induced oral erythema multiforme: Case report |
title_sort | drug induced oral erythema multiforme: case report |
topic | 5900 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084015/ https://www.ncbi.nlm.nih.gov/pubmed/33907086 http://dx.doi.org/10.1097/MD.0000000000022387 |
work_keys_str_mv | AT asifshaikmohamed druginducedoralerythemamultiformecasereport AT shamsudeenshaikmohamed druginducedoralerythemamultiformecasereport AT assirikhalilibrahim druginducedoralerythemamultiformecasereport AT muburakhussainmohammedal druginducedoralerythemamultiformecasereport AT kaleemsultanmohammed druginducedoralerythemamultiformecasereport AT khanabdulahad druginducedoralerythemamultiformecasereport AT shariffmansoor druginducedoralerythemamultiformecasereport |